Related Experiment Videos
The treatment of zinc deficiency is an immunotherapy
International Journal of Immunopharmacology
|September 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.
Cell death and differentiation·2009
IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
Annals of the New York Academy of Sciences·2007
Neuroendocrine immune interactions in health and disease.
International immunopharmacology·2003
A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma.
International immunopharmacology·2002
Immunomodulatory properties of Mycoplasma pulmonis. II. Studies on the mechanisms of immunomodulation.
International immunopharmacology·2001
Immunomodulatory properties of Mycoplasma pulmonis. I. Characterization of the immunomodulatory activity.
International immunopharmacology·2001
Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D.
International journal of immunopharmacology·2003
[3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine.
International journal of immunopharmacology·2003
Immunotoxicology: role of inflammation in chemical-induced hepatotoxicity.
International journal of immunopharmacology·2001